Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.75656 | 81 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.8031 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.80542 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.13514 | 82 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.76415 | 80 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.42769 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.22363 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.71786 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.78135 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.0234 | 82 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.78413 | 81 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.78417 | 81 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.82736 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.06221 | 83 |